The Role of the Innate Immune Response in Oral Mucositis Pathogenesis.
inflammation
innate immunity
interventions
oral mucositis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Nov 2023
14 Nov 2023
Historique:
received:
07
10
2023
revised:
11
11
2023
accepted:
12
11
2023
medline:
27
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Oral mucositis (OM) is a significant complication of cancer therapy with limited management strategies. Whilst inflammation is a central feature of destructive and ultimately ulcerative pathology, to date, attempts to mitigate damage via this mechanism have proven limited. A relatively underexamined aspect of OM development is the contribution of elements of the innate immune system. In particular, the role played by barriers, pattern recognition systems, and microbial composition in early damage signaling requires further investigation. As such, this review highlights the innate immune response as a potential focus for research to better understand OM pathogenesis and development of interventions for patients treated with radiotherapy and chemotherapy. Future areas of evaluation include manipulation of microbial-mucosal interactions to alter cytotoxic sensitivity, use of germ-free models, and translation of innate immune-targeted agents interrogated for mucosal injury in other regions of the alimentary canal into OM-based clinical trials.
Identifiants
pubmed: 38003503
pii: ijms242216314
doi: 10.3390/ijms242216314
pmc: PMC10670995
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Pineal Res. 2015 Jan;58(1):34-49
pubmed: 25388914
Semin Immunopathol. 2018 Nov;40(6):555-565
pubmed: 30182191
Nat Rev Cancer. 2004 Apr;4(4):277-84
pubmed: 15057287
Tissue Barriers. 2020 Jul 2;8(3):1804249
pubmed: 32835592
Drug Des Devel Ther. 2021 Mar 05;15:1021-1029
pubmed: 33716500
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966
pubmed: 27745982
Support Care Cancer. 2019 Oct;27(10):3949-3967
pubmed: 31286232
J Oral Maxillofac Pathol. 2019 Jan-Apr;23(1):122-128
pubmed: 31110428
Support Care Cancer. 2023 Jan 6;31(1):98
pubmed: 36607434
J Support Oncol. 2007 Oct;5(9 Suppl 4):3-11
pubmed: 18046993
J Cell Physiol. 2021 Feb;236(2):877-888
pubmed: 32730645
Trials. 2020 Nov 23;21(1):948
pubmed: 33225965
J Exp Clin Cancer Res. 2020 Oct 7;39(1):210
pubmed: 33028357
Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):343-52
pubmed: 11380220
Klin Lab Diagn. 2020 Sep 17;65(10):645-648
pubmed: 33245655
Cell. 2020 Mar 19;180(6):1044-1066
pubmed: 32164908
Cells. 2023 Jan 02;12(1):
pubmed: 36611977
J Dent Res. 2016 Jul;95(7):725-33
pubmed: 27053118
Cancer Immunol Res. 2020 Oct;8(10):1230-1235
pubmed: 33004412
EPMA J. 2019 Feb 25;10(1):43-50
pubmed: 30984313
Support Care Cancer. 2019 Oct;27(10):3985-3995
pubmed: 31286230
Oral Dis. 2010 Oct;16(7):655-60
pubmed: 20412446
Front Oral Health. 2022 Aug 18;3:917860
pubmed: 36060117
Cell Host Microbe. 2016 Nov 9;20(5):606-617
pubmed: 27923704
Arch Oral Biol. 2014 Feb;59(2):193-8
pubmed: 24370191
Nat Rev Immunol. 2010 Jul;10(7):479-89
pubmed: 20559326
Comput Struct Biotechnol J. 2021 Oct 25;19:5898-5910
pubmed: 34815834
J Clin Oncol. 2018 Oct 1;36(28):2872-2878
pubmed: 30125216
Cell Microbiol. 2013 Aug;15(8):1419-26
pubmed: 23433011
J Clin Microbiol. 2005 Nov;43(11):5721-32
pubmed: 16272510
Mucosal Immunol. 2019 Sep;12(5):1070-1081
pubmed: 30647411
Nat Rev Mol Cell Biol. 2020 Nov;21(11):678-695
pubmed: 32873928
Front Cell Infect Microbiol. 2022 Jun 02;12:831387
pubmed: 35719331
J Oral Pathol Med. 2015 Nov;44(10):857-63
pubmed: 25482673
Trends Immunol. 2016 Feb;37(2):84-101
pubmed: 26755064
Am Soc Clin Oncol Educ Book. 2012;:545-51
pubmed: 24451793
J Hosp Infect. 2003 Apr;53(4):283-91
pubmed: 12660125
Crit Rev Oncol Hematol. 2016 Mar;99:100-6
pubmed: 26712589
Science. 2014 Mar 28;343(6178):1249288
pubmed: 24625929
Oral Oncol. 2020 Mar;102:104559
pubmed: 31923856
Int J Mol Sci. 2021 Jul 22;22(15):
pubmed: 34360589
J Antimicrob Chemother. 2009 May;63 Suppl 1:i36-40
pubmed: 19372181
Oral Dis. 2015 Jan;21(1):17-30
pubmed: 24456144
Nature. 2016 Jul 06;535(7610):65-74
pubmed: 27383981
Front Cell Infect Microbiol. 2022 Dec 20;12:1070322
pubmed: 36605128
Biomed Pharmacother. 2021 Feb;134:111152
pubmed: 33373916
Support Care Cancer. 2021 Sep;29(9):4939-4947
pubmed: 33712912
Cancers (Basel). 2022 Mar 04;14(5):
pubmed: 35267634
Mol Oncol. 2020 Dec;14(12):2994-3006
pubmed: 33179413
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:1-13
pubmed: 2700931
Anticancer Res. 2019 Apr;39(4):1935-1942
pubmed: 30952736
Biomed Pharmacother. 2019 Oct;118:109217
pubmed: 31302424
Front Vet Sci. 2022 Aug 12;9:839467
pubmed: 36032288
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):228-34
pubmed: 22000579
Support Care Cancer. 2020 Jun;28(6):2683-2691
pubmed: 31650293
J Leukoc Biol. 2018 Mar;103(3):409-419
pubmed: 29345366
Front Physiol. 2018 Oct 31;9:1534
pubmed: 30429801
J Immunotoxicol. 2020 Dec;17(1):31-42
pubmed: 32013650
Mol Cancer Ther. 2016 Jun;15(6):1376-86
pubmed: 27197307
Support Care Cancer. 2016 Apr;24(4):1779-88
pubmed: 26441079
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E337-E346
pubmed: 28049839
Mediators Inflamm. 2010;2010:
pubmed: 20706656
Sci Rep. 2022 May 11;12(1):6803
pubmed: 35546555
Cancer. 2020 Oct 1;126(19):4423-4431
pubmed: 32786044
Oral Dis. 2007 Mar;13(2):170-6
pubmed: 17305618
J Clin Med. 2020 May 13;9(5):
pubmed: 32414103
Curr Opin Support Palliat Care. 2016 Jun;10(2):157-64
pubmed: 26986508
Int J Mol Sci. 2022 Aug 24;23(17):
pubmed: 36076990
Cancer Chemother Pharmacol. 2008 Jun;62(1):33-41
pubmed: 17703303
Am J Clin Dermatol. 2018 Nov;19(Suppl 1):31-39
pubmed: 30374901
Nutrients. 2018 Feb 13;10(2):
pubmed: 29438282
Curr Opin Support Palliat Care. 2017 Dec;11(4):341-346
pubmed: 28984677
Asian Pac J Cancer Prev. 2023 Jul 01;24(7):2445-2454
pubmed: 37505779
Br J Cancer. 2003 Apr 7;88(7):1012-6
pubmed: 12671696
Front Immunol. 2021 Jun 17;12:687627
pubmed: 34220843
J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53):
pubmed: 31425598
Biotechnol Rep (Amst). 2017 May 17;15:24-26
pubmed: 28649557
PLoS One. 2021 Mar 26;16(3):e0249343
pubmed: 33770116
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
Trends Immunol. 2005 Aug;26(8):447-54
pubmed: 15967716
Exp Anim. 2020 Apr 24;69(2):144-152
pubmed: 31787709
J Pathol. 2012 Mar;226(4):598-608
pubmed: 21960132
Future Oncol. 2017 Dec;13(30):2823-2852
pubmed: 29192505
Expert Rev Clin Immunol. 2023 Apr;19(4):405-415
pubmed: 36803467
Front Cell Infect Microbiol. 2019 Aug 07;9:282
pubmed: 31448244
Nurs Open. 2023 Nov;10(11):7292-7300
pubmed: 37632251
Int J Mol Sci. 2023 May 05;24(9):
pubmed: 37175980
EBioMedicine. 2017 Apr;18:23-31
pubmed: 28216066
J Oral Pathol Med. 2015 Feb;44(2):81-7
pubmed: 24494824
Front Immunol. 2019 Feb 14;10:208
pubmed: 30837987
Curr Opin Oncol. 2015 May;27(3):159-64
pubmed: 25774860
Cancer Chemother Pharmacol. 2009 Jan;63(2):239-51
pubmed: 18351341
Cell Host Microbe. 2014 Mar 12;15(3):374-81
pubmed: 24629343
Front Oral Health. 2022 Mar 28;3:881949
pubmed: 35419563
J Clin Med. 2021 Sep 27;10(19):
pubmed: 34640462
Exp Ther Med. 2019 Sep;18(3):1961-1966
pubmed: 31452696
EXCLI J. 2019 Jun 07;18:317-330
pubmed: 31338005
Oral Dis. 2015 Mar;21(2):133-41
pubmed: 24131518
Arch Oral Biol. 2019 Oct;106:104480
pubmed: 31325717
Molecules. 2023 Mar 24;28(7):
pubmed: 37049698
Cancer. 2004 May 1;100(9 Suppl):1995-2025
pubmed: 15108222
Curr Opin Immunol. 2014 Feb;26:41-8
pubmed: 24556399
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
Int J Hematol. 2020 Nov;112(5):690-696
pubmed: 32770478
Oral Surg Oral Med Oral Pathol. 1989 Feb;67(2):154-61
pubmed: 2919059
Basic Clin Pharmacol Toxicol. 2023 Jun;132(6):511-520
pubmed: 36878867